1. Report Overview
1.1. Market Definition
1.2. Why Should You Read This Report?
1.3. How This Report Delivers?
1.4. Key Questions Answered by This Analytical Report:
1.5. Who is this Report for?
1.6. Research Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. About Visiongain
2. Introduction To The Plasma Protein Therapeutic Market
2.1. What are Plasma Protein Therapeutic?
2.2. Global Plasma Protein Therapeutic Market Segmentation
2.3. Assumptions For The Study
3. Qualitative Analysis of the Global Plasma Protein Therapeutic Market
3.1. SWOT Analysis of The Global Plasma Protein Therapeutic Market
3.2. PESTLE Analysis
3.3. Market Trends
3.4. Drivers
3.4.1. Increasing geriatric population
3.4.2. Rising disposable income
3.4.3. Favorable reimbursement scenario
3.5. Restraints
3.5.1. Lack of skilled professionals
3.6. Opportunity
3.6.1. Technological advancements
4. Global Plasma Protein Therapeutic Market, by Product, 2020-2030
4.1. Global Plasma Protein Therapeutic Market Forecast, 2020-2030
4.2. ALBUMIN
4.2.1. Plasma Protein Therapeutic Market, for ALBUMIN, by Region: Market Forecasts 2020-2030
4.3. Immunoglobulin
4.3.1. Plasma Protein Therapeutic Market, for Immunoglobulin, by Region: Market Forecasts 2020-2030
4.4. Alpha-1 Proteinase Inhibitor
4.4.1. Plasma Protein Therapeutic Market, for Alpha-1 Proteinase Inhibitor, by Region: Market Forecasts 2020-2030
4.5. Coagulation Factors
4.5.1. Plasma Protein Therapeutic Market, for Coagulation Factors, by Region: Market Forecasts 2020-2030
5. Global Plasma Protein Therapeutic Market, by Application, 2020-2030
5.1. Global Plasma Protein Therapeutic Market Forecast, 2020-2030
5.2. Hemophilia
5.2.1. Plasma Protein Therapeutic Market, for Hemophilia, by Region: Market Forecasts 2020-2030
5.3. Primary Immunodeficiency Disorder
5.3.1. Plasma Protein Therapeutic Market, for Primary Immunodeficiency Disorder, by Region: Market Forecasts 2020-2030
5.4. Idiopathic Thrombocytopenic Purpura
5.4.1. Plasma Protein Therapeutic Market, for Idiopathic Thrombocytopenic Purpura, by Region: Market Forecasts 2020-2030
5.5. Others
5.5.1. Plasma Protein Therapeutic Market, for Others, by Region: Market Forecasts 2020-2030
6. Leading National Markets Forecast 2020-2030
6.1. Geographical Breakdown of Global Plasma Protein Therapeutic Market, 2019
7. North America Plasma Protein Therapeutic Market, 2020-2030
7.1. U.S. Plasma Protein Therapeutic Market Forecast, 2020-2030
7.2. U.S Plasma Protein Therapeutic Market, Trends and Developments
7.3. Canada Plasma Protein Therapeutic Market Forecast, 2020-2030
7.4. Canada Plasma Protein Therapeutic Market, Trends and Developments
8. Europe Plasma Protein Therapeutic Market, 2020-2030
8.1. Germany Plasma Protein Therapeutic Market Forecast, 2020-2030
8.2. Germany Plasma Protein Therapeutic Market, Trends and Developments
8.3. France Plasma Protein Therapeutic Market Forecast, 2020-2030
8.4. France Plasma Protein Therapeutic Market, Trends and Developments
8.5. UK Plasma Protein Therapeutic Market Forecast, 2020-2030
8.6. UK Plasma Protein Therapeutic Market, Trends and Developments
8.7. Italy Plasma Protein Therapeutic Market Forecast, 2020-2030
8.8. Italy Plasma Protein Therapeutic Market, Trends and Developments
8.9. Spain Plasma Protein Therapeutic Market Forecast, 2020-2030
8.10. Spain Plasma Protein Therapeutic Market, Trends and Developments
8.11. Rest of Europe Plasma Protein Therapeutic Market Forecast, 2020-2030
8.12. Rest of Europe Plasma Protein Therapeutic Market, Trends and Developments
9. Asia Pacific Plasma Protein Therapeutic Market, 2020-2030
9.1. Japan Plasma Protein Therapeutic Market Forecast, 2020-2030
9.2. Japan Plasma Protein Therapeutic Market, Trends and Developments
9.3. China Plasma Protein Therapeutic Market Forecast, 2020-2030
9.4. China Plasma Protein Therapeutic Market, Trends and Developments
9.5. India Plasma Protein Therapeutic Market Forecast, 2020-2030
9.6. India Plasma Protein Therapeutic Market, Trends and Developments
9.7. Australia Plasma Protein Therapeutic Market Forecast, 2020-2030
9.8. Australia Plasma Protein Therapeutic Market, Trends and Developments
9.9. Rest of APAC Plasma Protein Therapeutic Market Forecast, 2020-2030
9.10. Rest of APAC Plasma Protein Therapeutic Market, Trends and Developments
10. Latin America Plasma Protein Therapeutic Market, 2020-2030
10.1. Brazil Plasma Protein Therapeutic Market Forecast, 2020-2030
10.2. Brazil Plasma Protein Therapeutic Market, Trends and Developments
10.3. Mexico Plasma Protein Therapeutic Market Forecast, 2020-2030
10.4. Mexico Plasma Protein Therapeutic Market, Trends and Developments
10.5. Rest of Latin America Plasma Protein Therapeutic Market Forecast, 2020-2030
10.6. Rest of Latin America Plasma Protein Therapeutic Market, Trends and Developments
11. MEA Plasma Protein Therapeutic Market, 2020-2030
11.1. GCC Countries Plasma Protein Therapeutic Market Forecast, 2020-2030
11.2. GCC Countries Plasma Protein Therapeutic Market, Trends and Developments
11.3. South Africa Plasma Protein Therapeutic Market Forecast, 2020-2030
11.4. South Africa Plasma Protein Therapeutic Market, Trends and Developments
11.5. Rest of MEA Plasma Protein Therapeutic Market Forecast, 2020-2030
11.6. Rest of MEA Plasma Protein Therapeutic Market, Trends and Developments
12. Leading Plasma Protein Therapeutic Companies
12.1. CSL Behring LLC
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.3. Sales Analysis
12.2. Baxter International
12.2.1. Company Overview
12.2.2. Product Portfolio
12.2.3. Sales Analysis
12.3. China Biologics
12.3.1. Company Overview
12.3.2. Product Portfolio
12.3.3. Sales Analysis
12.4. Octapharma AG
12.4.1. Company Overview
12.4.2. Product Portfolio
12.4.3. Sales Analysis
12.5. Grifols S.A.
12.5.1. Company Overview
12.5.2. Product Portfolio
12.5.3. Sales Analysis
12.6. Shire Plc
12.6.1. Company Overview
12.6.2. Product Portfolio
12.6.3. Sales Analysis
12.7. Bayer AG
12.7.1. Company Overview
12.7.2. Product Portfolio
12.7.3. Sales Analysis
12.8. Biotest AG
12.8.1. Company Overview
12.8.2. Product Portfolio
12.8.3. Sales Analysis
12.9. Kedrion S.P.A.
12.9.1. Company Overview
12.9.2. Product Portfolio
12.9.3. Sales Analysis
13. Conclusion & Recommendations
14. Glossary
14.1. Associated Visiongain Reports
14.2. Visiongain Report Sales Order Form
14.3. About Visiongain
14.4. Visiongain report evaluation form
List of Tables
Table 4.1. Global Plasma Protein Therapeutic Market, by Product, Forecast ($Mn, AGR%), 2020-2030
Table 4.2. Global Plasma Protein Therapeutic Market, for Albumin, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 4.3. Global Plasma Protein Therapeutic Market, for Immunoglobulin, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 4.4. Global Plasma Protein Therapeutic Market, by Alpha-1 Proteinase Inhibitor, Forecast ($Mn, AGR%), 2020-2030
Table 4.5. Global Plasma Protein Therapeutic Market for Coagulation Factors, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.1. Global Plasma Protein Therapeutic Market, by Application, Forecast ($Mn, AGR%), 2020-2030
Table 5.2. Global Plasma Protein Therapeutic Market for Hemophilia, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.3. Global Plasma Protein Therapeutic Market for Primary Immunodeficiency Disorder, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.4. Global Plasma Protein Therapeutic Market for Idiopathic Thrombocytopenic Purpura, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.5. Global Plasma Protein Therapeutic Market for Others, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 7.1 North American Plasma Protein Therapeutic Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 7.2 North American Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 7.3 North American Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 7.4 US Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 7.5 US Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 7.6 Canada Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 7.7 Canada Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.1 Europe Plasma Protein Therapeutic Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 8.2 Europe Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.3 Europe Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.4 Germany Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.5 Germany Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.6 France Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.7 France Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.8 UK Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.9 UK Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.10 Spain Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.11 Spain Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.12 Italy Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.13 Italy Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 8.14 Rest of Europe Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 8.15 Rest of Europe Plasma Protein Therapeutic Market Forecast, by , 2020-2030 ($Mn, AGR%)
Table 8.16 Rest of Europe Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.1 Asia-Pacific Plasma Protein Therapeutic Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 9.2 Asia-Pacific Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.3 Asia-Pacific Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.4 China Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.5 China Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.6 Japan Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.7 Japan Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.8 India Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.9 India Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.10 Australia Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.11 Australia Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 9.12 Rest of Asia-Pacific Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 9.13 Rest of Asia-Pacific Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 10.1 Latin America Plasma Protein Therapeutic Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 10.2 Latin America Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 10.3 Latin America Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 10.4 Brazil Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 10.5 Brazil Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 10.6 Mexico Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 10.7 Mexico Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 10.8 Rest of Latin America Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 10.9 Rest of Latin America Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 11.1 Middle East & Africa Plasma Protein Therapeutic Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 11.2 Middle East & Africa Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 11.3 Middle East & Africa Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 11.4 GCC Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 11.5 GCC Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 11.6 South Africa Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 11.7 South Africa Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 11.8 Rest of Middle East & Africa Plasma Protein Therapeutic Market Forecast, by Product, 2020-2030 ($Mn, AGR%)
Table 11.9 Rest of Middle East & Africa Plasma Protein Therapeutic Market Forecast, by Application, 2020-2030 ($Mn, AGR%)
Table 12.1 CSL Behring LLC Product Portfolio
Table 12.2 Baxter International Product Portfolio
Table 12.3 China Biologics Product Portfolio
Table 12.4 Octapharma AG Product Portfolio
Table 12.5 Grifols S.A. Product Portfolio
Table 12.6 Shire Plc Product Portfolio
Table 12.7 Bayer AG Product Portfolio
Table 12.8 Biotest AG Product Portfolio
Table 12.9 Kedrion S.P.A. Product Portfolio
Table 12.10 McKesson Corporation Product Portfolio
List of Figures
Figure 4.1. Global Plasma Protein Therapeutic Market, by Product, Forecast ($Mn) 2020-2030
Figure 6.1. Global Plasma Protein Therapeutic Market, by Application, Forecast ($Mn) 2020-2030
Figure 7.1. Global Plasma Protein Therapeutic Market, by Region, Forecast ($Mn), 2020-2030
Figure 8.1 North American Plasma Protein Therapeutic Market Forecast, ($Mn), 2020-2030
Figure 9.1 Europe Plasma Protein Therapeutic Market Forecast, ($Mn), 2020-2030
Figure 10.1 Asia-Pacific Plasma Protein Therapeutic Market Forecast, ($Mn), 2020-2030
Figure 11.1 Latin America Plasma Protein Therapeutic Market Forecast, ($Mn), 2020-2030
Figure 12.1 Middle East & Africa Plasma Protein Therapeutic Market Forecast, ($Mn), 2020-2030
Figure 13.1 CSL Behring LLC Sales Analysis ($Mn)
Figure 13.2 Baxter International Sales Analysis ($Mn)
Figure 13.3 China Biologics Sales Analysis ($Mn)
Figure 13.4 Octapharma AG Sales Analysis ($Mn)
Figure 13.5 Grifols S.A. Sales Analysis ($Mn)
Figure 13.6 Shire Plc Sales Analysis ($Mn)
Figure 13.7 Bayer AG Sales Analysis ($Mn)
Figure 13.8 Biotest AG Corporation Sales Analysis ($Mn)
Figure 13.9 Kedrion S.P.A. Sales Analysis ($Mn)
Figure 13.10 McKesson Corporation Sales Analysis ($Mn)
